You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company plans to in particular use the funds to prepare a clinical trial of their anti-FcγRIIB antibody BI-1206 for the treatment of Non-Hodgkin's Lymphoma. The Board of Directors of BioInvent International has resolved to issue 19,095,000 shares in a directed share issue to international anAlready a subscriber Login You…
Cantargia has announced that the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) has issued a positive opinion for orphan designation of nadunolimab (CAN04) for treatment of pancreatic cancer. The European Commission is now expected to grant the orphan designAlready a subscriber Login You have read…
Lundbeck will begin research on a novel method for earlier and more precise diagnosis of Parkinson’s disease, the likes of which do not currently exist. By diagnosing Parkinson’s disease as early as possible, patients can benefit from a greater choice in treatment options. This research is fuAlready a subscriber Login…
Ferring Pharmaceuticals and North Zealand University Hospital (Nordsjællands Hospital) have formally inaugurated a multi-year collaboration aimed at transforming the way in which patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) manage their condition and receive meAlready a subscriber Login You have read all your free articles, to continue…
